Searched for
LUPIN PAT
Laurus Labs adds Rs 40,150 crore to investors' wealth in a year with 120% rally. Buy, hold or book profits?Laurus Labs has significantly boosted investor wealth, adding over Rs 40,000 crore in a year with a 120% stock rally. Driven by business im...- Buy, Sell or Hold: Motilal Oswal maintains neutral on Lupin; Citi maintains sell on Info EdgeBrokerages offer mixed stock recommendations, with pharma stocks like Lupin and Torrent Pharma seeing target price upgrades despite neutral...
- Stocks in news: Tata Steel, LG India, Honasa Consumer, SpiceJet, Hero MotoCorpIndian markets surged on Wednesday, buoyed by positive trade talks with the US and strong Q2 corporate earnings. Tata Steel reported a sign...
- Lupin shares jump 2% as Q2 PAT soars 73% YoY to Rs 1,485 croreLupin shares rose on Friday after the pharma major reported a robust 73% YoY surge in Q2 FY26 PAT to Rs 1,485 crore, driven by strong sales...
- Lupin shares jump 5% after strong Q1 results. Should you accumulate more?Lupin shares jumped 5% after reporting a 52% YoY rise in Q1 FY26 net profit to Rs 1,221 crore, driven by strong US and India sales. Revenue...
- Buy Lupin, target price Rs 1165: ICICI DirectLupin Ltd., incorporated in the year 1983, is a Large Cap company (having a market cap of Rs 47082.92 Crore) operating in Pharmaceuticals s...
- Lupin trades above Rs 1,000 for the first time since Nov 2017The pharma major last week reported a 64.72 per cent decline in its consolidated net profit to Rs 106.90 crore for the quarter to June 2020...
- Buy Lupin, target Rs 1,030: HDFC SecuritiesBuy Lupin at a price target of Rs 1030.
- Nifty at new highs, but enough good reasons to call it a mirageOnce the earnings season gets over, Mr Market will hopefully adjust to the global realities.
- Good home show to help Lupin limit fallout of US woesIndian pharmaceutical cos are facing regulatory issues and steep competition in US market.
- Buy Lupin, target Rs 1190: HDFC SecuritiesBuy Lupin Ltd. at a price target of Rs 1190.
- Add Lupin Ltd. target Rs 815: ICICI DirectAdd Lupin Ltd. at a price target of Rs 815.
- Pharma firms likely to post soft Q3, but low base may play saviourThe USFDA granted the highest-ever approvals in a single quarter with 246 clearances.
- Accumulate Lupin with a target of Rs 1650: Prabhudas LilladherDomestic formulations growth is also increased to 16.5 per cent from 14 per cent in FY17E-18E," Prabhudas said in a report.
- Mapping the market: ITC, logistics stocks played saviour when fears ruled D-StreetSebi’s stringent rules on participatory notes (P-Notes) did not prove that spooky, neither was the speculation about a June rate hike by US...
- Lupin nosedives 8% even as drugmaker reports 47% PAT growth in Q4The company had reported PAT of Rs 547 crore in the same quarter last financial year.
- Bet is on Zee Telefilms, Lupin: Yogesh Mehta, MOSL"We are projecting a price target of Rs 2250 for Lupin"
- Lupin Q2 PAT up 55% at Rs 630 cr; stock downThe company reported net sales of Rs 3,173.4 crore, up 20.6 per cent, against Rs 2,631 crore, Year-on-Year (YoY).
- Lupin's earnings outperform Street expectations, to stay our top pick: Kirit Gogri, Quant Broking"The US business has been a big game changer for Lupin and I am presuming that the US business would have delivered much superior numbers t...
- LUPIN
Load More
